Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.380 -0.020 (-1.41%)
Streaming Delayed Price Updated: 3:46 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 114,057
Open 1.430
Bid (Size) 1.380 (5)
Ask (Size) 1.400 (2)
Prev. Close 1.400
Today's Range 1.350 - 1.519
52wk Range 0.9101 - 3.480
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Profiled on Credit-Card-Sized Device That Synthesizes 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Three September Investor Conferences
Via Investor Brand Network
Topics Intellectual Property

Performance

YTD
-41.3%
-41.3%
1 Month
+38.0%
+38.0%
3 Month
-17.8%
-17.8%
6 Month
-34.6%
-34.6%
1 Year
-39.7%
-39.7%

More News

Read More
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Patient Convenience with At-Home ECG Technology
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q2 2025 Results, Advances Toward FDA Clearance and Commercial Launch
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
HeartBeam Cuts Costs Awaits FDA Decision
Via The Motley Fool
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
Via Chartmill
HeartBeam Reports Second Quarter 2025 Results
From HeartBeam, Inc.
Via Business Wire
Earnings Scheduled For August 13, 2025
Via Benzinga
HeartBeam Inc. (NASDAQ: BEAT) FDA-Cleared System Provides Momentum as Company Moves to Innovate Cardiac Care
Via Investor Brand Network
HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates
Via Investor Brand Network
Topics Intellectual Property
HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2025 Innovation Award for Remote Cardiac Diagnostics
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Present at iAccess Alpha Virtual Summer Conference
Via Investor Brand Network
Topics Intellectual Property
Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025
Via ACCESS Newswire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Via ACCESS Newswire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring
Via Investor Brand Network
Topics Intellectual Property

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 1.380
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 09/04/25 03:46 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 47.29M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 47M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.